Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Marcotte

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
BMC Infectious Diseases|August 23, 2011
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapsesPer-Göran Larsson, Erik Brandsborg, Urban Forsum, et al.
Pharmaceutics|January 21, 2023
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus InfectionYoshikazu Yuki, Fanglei Zuo, Shiho Kurokawa, et al.
Microbiological Research|September 26, 2017
Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag<sup>®</sup> probiotic vaginal capsulesHarold Marcotte, Kasper Krogh Andersen, Yin Lin, et al.
BMC Infectious Diseases|September 20, 2019
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosisHarold Marcotte, Per Göran Larsson, Kasper Krogh Andersen, et al.
Vaccines|December 16, 2020
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?Sarah Kalusche, Kanika Vanshylla, Franziska Kleipass, et al.
Infection and Immunity|November 18, 2015
Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain AntibodiesKasper Krogh Andersen, Nika M Strokappe, Anna Hultberg, et al.
Applied and Environmental Microbiology|January 25, 2011
Integrative expression system for delivery of antibody fragments by lactobacilliM Cruz Martín, Neha Pant, Victor Ladero, et al.
Current Microbiology|May 6, 2010
Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probioticsPiret Kõll, Reet Mändar, Imbi Smidt, et al.
Journal of Virological Methods|September 7, 2025
Evaluation of two IgG-scFv bispecific antibodies for neutralizing Omicron variants of SARS-CoV-2Diana Hinojosa-Trujillo, Freddy Dehesa-Canseco, Melissa García-Vega, et al.
Applied and Environmental Microbiology|June 21, 2015
An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its SurfaceBeatriz Álvarez, Kasper Krogh-Andersen, Christian Tellgren-Roth, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|August 23, 2011
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapsesPer-Göran Larsson, Erik Brandsborg, Urban Forsum, et al.
Pharmaceutics|January 21, 2023
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus InfectionYoshikazu Yuki, Fanglei Zuo, Shiho Kurokawa, et al.
Microbiological Research|September 26, 2017
Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag<sup>®</sup> probiotic vaginal capsulesHarold Marcotte, Kasper Krogh Andersen, Yin Lin, et al.
BMC Infectious Diseases|September 20, 2019
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosisHarold Marcotte, Per Göran Larsson, Kasper Krogh Andersen, et al.
Vaccines|December 16, 2020
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?Sarah Kalusche, Kanika Vanshylla, Franziska Kleipass, et al.
Infection and Immunity|November 18, 2015
Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain AntibodiesKasper Krogh Andersen, Nika M Strokappe, Anna Hultberg, et al.
Applied and Environmental Microbiology|January 25, 2011
Integrative expression system for delivery of antibody fragments by lactobacilliM Cruz Martín, Neha Pant, Victor Ladero, et al.
Current Microbiology|May 6, 2010
Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probioticsPiret Kõll, Reet Mändar, Imbi Smidt, et al.
Journal of Virological Methods|September 7, 2025
Evaluation of two IgG-scFv bispecific antibodies for neutralizing Omicron variants of SARS-CoV-2Diana Hinojosa-Trujillo, Freddy Dehesa-Canseco, Melissa García-Vega, et al.
Applied and Environmental Microbiology|June 21, 2015
An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its SurfaceBeatriz Álvarez, Kasper Krogh-Andersen, Christian Tellgren-Roth, et al.
Pageof 5